EA201170224A1 - Новые производные имидазо[1,2-a]пиримидинов, способ их получения, их применение в качестве лекарственных средств, фармацевтические композиции и новое применение, в частности, в качестве ингибиторов мет - Google Patents
Новые производные имидазо[1,2-a]пиримидинов, способ их получения, их применение в качестве лекарственных средств, фармацевтические композиции и новое применение, в частности, в качестве ингибиторов метInfo
- Publication number
- EA201170224A1 EA201170224A1 EA201170224A EA201170224A EA201170224A1 EA 201170224 A1 EA201170224 A1 EA 201170224A1 EA 201170224 A EA201170224 A EA 201170224A EA 201170224 A EA201170224 A EA 201170224A EA 201170224 A1 EA201170224 A1 EA 201170224A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- new
- medicines
- ingitiators
- pyrimidines
- production
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
- C07D277/62—Benzothiazoles
- C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D277/82—Nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Neurology (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Obesity (AREA)
- Cardiology (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Urology & Nephrology (AREA)
- Endocrinology (AREA)
- Neurosurgery (AREA)
- Ophthalmology & Optometry (AREA)
- Dermatology (AREA)
- Emergency Medicine (AREA)
- Vascular Medicine (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Изобретение относится к новым продуктам формулы (I), в которой n=0, 1 или 2; Х означает Н, Гал или алк; R означает Н, NH, NH(алк), N(алк); Ra означает Н; Гал; -O-циклоалкил, -O-алкил, -O-арил; -O-гетероарил; -NRd(циклоалкил); -NRd(алкил); -NRd(арил); -NRd(гетероарил); алкил; циклоалкил; гетероциклоалкил; арил или гетероарил; все радикалы необязательно замещены; Rb означает Н, Rc, -COORc-CO-Rc или -CO-NRcRd, где Rc означает алкил, циклоалкил, гетероциклоалкил, арил и гетероарил, все радикалы необязательно замещены; Rd означает Н, алк или циклоалкил; указанные продукты находятся во всех изомерных формах и в форме солей используют в качестве лекарственных средств, в частности, в качестве ингибиторов MET.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0804086A FR2933982A1 (fr) | 2008-07-18 | 2008-07-18 | Nouveaux derives imidazo°1,2-a!pyrimidine, leur procede de preparation, leur application a titre de medicaments, compositions pharmaceutiques et nouvelle utilisation notamment comme inhibiteurs de met |
PCT/FR2009/051408 WO2010007318A2 (fr) | 2008-07-18 | 2009-07-16 | NOUVEAUX DERIVES IMIDAZO[1,2-a]PYRIMIDINE, LEUR PROCEDE DE PREPARATION, LEUR APPLICATION A TITRE DE MEDICAMENTS, COMPOSITIONS PHARMACEUTIQUES ET NOUVELLE UTILISATION NOTAMMENT COMME INHIBITEURS DE MET |
Publications (1)
Publication Number | Publication Date |
---|---|
EA201170224A1 true EA201170224A1 (ru) | 2011-08-30 |
Family
ID=40352183
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA201170224A EA201170224A1 (ru) | 2008-07-18 | 2009-07-16 | Новые производные имидазо[1,2-a]пиримидинов, способ их получения, их применение в качестве лекарственных средств, фармацевтические композиции и новое применение, в частности, в качестве ингибиторов мет |
Country Status (26)
Country | Link |
---|---|
US (1) | US20110263593A1 (ru) |
EP (1) | EP2318414A2 (ru) |
JP (1) | JP2011528339A (ru) |
KR (1) | KR20110043680A (ru) |
CN (1) | CN102159577A (ru) |
AR (1) | AR072820A1 (ru) |
AU (1) | AU2009272518A1 (ru) |
BR (1) | BRPI0915920A2 (ru) |
CA (1) | CA2730964A1 (ru) |
CL (1) | CL2011000118A1 (ru) |
CO (1) | CO6341634A2 (ru) |
CR (1) | CR20110031A (ru) |
DO (1) | DOP2011000019A (ru) |
EA (1) | EA201170224A1 (ru) |
EC (1) | ECSP11010765A (ru) |
FR (1) | FR2933982A1 (ru) |
IL (1) | IL210708A0 (ru) |
MA (1) | MA32564B1 (ru) |
MX (1) | MX2011000670A (ru) |
NI (1) | NI201100020A (ru) |
PE (1) | PE20110584A1 (ru) |
SV (1) | SV2011003811A (ru) |
TW (1) | TW201011025A (ru) |
UY (1) | UY31998A (ru) |
WO (1) | WO2010007318A2 (ru) |
ZA (1) | ZA201100428B (ru) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20100041663A1 (en) | 2008-07-18 | 2010-02-18 | Novartis Ag | Organic Compounds as Smo Inhibitors |
US8759535B2 (en) | 2010-02-18 | 2014-06-24 | High Point Pharmaceuticals, Llc | Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof |
WO2011121223A1 (fr) | 2010-03-30 | 2011-10-06 | Sanofi-Aventis | Derives de 6-(alkyl- ou cycloalkyl-triazolopyridazine-sulfanyl) benzothiazoles: preparation, application comme medicaments et utilisation comme inhibiteurs de met |
CN102796103A (zh) * | 2011-05-23 | 2012-11-28 | 南京英派药业有限公司 | 6-(芳基甲酰)咪唑并[1,2-a]嘧啶和6-(芳基甲酰)[1,2,4]三唑并[4,3-a]嘧啶作为Hedgehog抑制剂及其应用 |
WO2016089648A1 (en) | 2014-12-01 | 2016-06-09 | Vtv Therapeutics Llc | Bach 1 inhibitors in combination with nrf2 activators and pharmaceutical compositions thereof |
CN111936136A (zh) | 2017-11-14 | 2020-11-13 | 儿童医学中心公司 | 新咪唑并嘧啶化合物及其用途 |
KR20200088398A (ko) | 2017-11-14 | 2020-07-22 | 칠드런'즈 메디컬 센터 코포레이션 | 인간 면역 반응을 조정하기 위한 이미다조피리미딘의 용도 |
US20220143049A1 (en) | 2019-03-21 | 2022-05-12 | Onxeo | A dbait molecule in combination with kinase inhibitor for the treatment of cancer |
EP4054579A1 (en) | 2019-11-08 | 2022-09-14 | Institut National de la Santé et de la Recherche Médicale (INSERM) | Methods for the treatment of cancers that have acquired resistance to kinase inhibitors |
WO2021148581A1 (en) | 2020-01-22 | 2021-07-29 | Onxeo | Novel dbait molecule and its use |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2785157A (en) * | 1952-11-05 | 1957-03-12 | Eastman Kodak Co | Benzothiazoleazoaniline compounds |
IL133800A0 (en) * | 1997-07-03 | 2001-04-30 | Du Pont Pharm Co | Imidazopyrimidines and imidazopyridines for the treatment of neurological disorders |
EP1112269A2 (en) * | 1998-09-11 | 2001-07-04 | Warner-Lambert Company | Hiv protease inhibitors |
MXPA02007632A (es) * | 2000-02-07 | 2004-08-23 | Abbott Gmbh & Co Kg | Derivados de 2-benzotiazolil urea y su uso como inhibidores de proteina cinasa. |
EP1711495A2 (en) * | 2004-01-23 | 2006-10-18 | Amgen Inc. | Quinoline, quinazoline, pyridine and pyrimidine counds and their use in the treatment of inflammation, angiogenesis and cancer |
WO2006038001A1 (en) * | 2004-10-06 | 2006-04-13 | Celltech R & D Limited | Aminopyrimidine derivatives as jnk inhibitors |
EP1674466A1 (en) * | 2004-12-27 | 2006-06-28 | 4Sc Ag | 2,5- and 2,6-disubstituted benzazole analogues useful as protein kinase inhibitors |
PL2099447T3 (pl) * | 2006-11-22 | 2013-06-28 | Incyte Holdings Corp | Imidazotriazyny i imidazopirmidyny jako inhibitory kinaz |
-
2008
- 2008-07-18 FR FR0804086A patent/FR2933982A1/fr not_active Withdrawn
-
2009
- 2009-07-16 CA CA2730964A patent/CA2730964A1/fr not_active Abandoned
- 2009-07-16 CN CN200980136540XA patent/CN102159577A/zh active Pending
- 2009-07-16 AU AU2009272518A patent/AU2009272518A1/en not_active Abandoned
- 2009-07-16 WO PCT/FR2009/051408 patent/WO2010007318A2/fr active Application Filing
- 2009-07-16 BR BRPI0915920-7A patent/BRPI0915920A2/pt not_active IP Right Cessation
- 2009-07-16 KR KR1020117003698A patent/KR20110043680A/ko not_active Application Discontinuation
- 2009-07-16 TW TW098124145A patent/TW201011025A/zh unknown
- 2009-07-16 PE PE2011000049A patent/PE20110584A1/es not_active Application Discontinuation
- 2009-07-16 JP JP2011517980A patent/JP2011528339A/ja not_active Withdrawn
- 2009-07-16 MX MX2011000670A patent/MX2011000670A/es not_active Application Discontinuation
- 2009-07-16 EP EP09737062A patent/EP2318414A2/fr not_active Withdrawn
- 2009-07-16 EA EA201170224A patent/EA201170224A1/ru unknown
- 2009-07-17 AR ARP090102728A patent/AR072820A1/es unknown
- 2009-07-17 UY UY0001031998A patent/UY31998A/es not_active Application Discontinuation
-
2011
- 2011-01-17 CR CR20110031A patent/CR20110031A/es not_active Application Discontinuation
- 2011-01-17 ZA ZA2011/00428A patent/ZA201100428B/en unknown
- 2011-01-17 DO DO2011000019A patent/DOP2011000019A/es unknown
- 2011-01-17 US US13/007,830 patent/US20110263593A1/en not_active Abandoned
- 2011-01-17 SV SV2011003811A patent/SV2011003811A/es unknown
- 2011-01-17 NI NI201100020A patent/NI201100020A/es unknown
- 2011-01-17 IL IL210708A patent/IL210708A0/en unknown
- 2011-01-18 CL CL2011000118A patent/CL2011000118A1/es unknown
- 2011-01-18 CO CO11004605A patent/CO6341634A2/es not_active Application Discontinuation
- 2011-01-18 EC EC2011010765A patent/ECSP11010765A/es unknown
- 2011-02-15 MA MA33618A patent/MA32564B1/fr unknown
Also Published As
Publication number | Publication date |
---|---|
SV2011003811A (es) | 2011-04-29 |
CO6341634A2 (es) | 2011-11-21 |
TW201011025A (en) | 2010-03-16 |
ECSP11010765A (es) | 2011-02-28 |
EP2318414A2 (fr) | 2011-05-11 |
UY31998A (es) | 2010-02-26 |
ZA201100428B (en) | 2012-03-28 |
DOP2011000019A (es) | 2011-02-15 |
JP2011528339A (ja) | 2011-11-17 |
WO2010007318A3 (fr) | 2010-04-08 |
CR20110031A (es) | 2011-03-14 |
PE20110584A1 (es) | 2011-09-10 |
WO2010007318A2 (fr) | 2010-01-21 |
BRPI0915920A2 (pt) | 2018-07-10 |
IL210708A0 (en) | 2011-03-31 |
US20110263593A1 (en) | 2011-10-27 |
MX2011000670A (es) | 2011-04-11 |
NI201100020A (es) | 2011-07-21 |
FR2933982A1 (fr) | 2010-01-22 |
AU2009272518A1 (en) | 2010-01-21 |
AR072820A1 (es) | 2010-09-22 |
MA32564B1 (fr) | 2011-08-01 |
KR20110043680A (ko) | 2011-04-27 |
CN102159577A (zh) | 2011-08-17 |
CA2730964A1 (fr) | 2010-01-21 |
CL2011000118A1 (es) | 2011-07-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA201170224A1 (ru) | Новые производные имидазо[1,2-a]пиримидинов, способ их получения, их применение в качестве лекарственных средств, фармацевтические композиции и новое применение, в частности, в качестве ингибиторов мет | |
EA201170223A1 (ru) | НОВЫЕ ПРОИЗВОДНЫЕ ИМИДАЗО[1,2-a]ПИРИДИНА, СПОСОБ ИХ ПОЛУЧЕНИЯ, ИХ ПРИМЕНЕНИЕ В КАЧЕСТВЕ ЛЕКАРСТВЕННЫХ СРЕДСТВ, ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ И НОВОЕ ПРИМЕНЕНИЕ, В ЧАСТНОСТИ, В КАЧЕСТВЕ ИНГИБИТОРОВ МЕТ | |
EA201170222A1 (ru) | НОВЫЕ ПРОИЗВОДНЫЕ ТРИАЗОЛО[4,3-a]ПИРИДИНА, СПОСОБ ИХ ПОЛУЧЕНИЯ, ИХ ПРИМЕНЕНИЕ В КАЧЕСТВЕ ЛЕКАРСТВЕННЫХ СРЕДСТВ, ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ И НОВОЕ ПРИМЕНЕНИЕ, В ЧАСТНОСТИ, В КАЧЕСТВЕ ИНГИБИТОРОВ МЕТ | |
EA200870192A1 (ru) | Новые серосодержащие производные циклической мочевины, их получение и их фармацевтическое применение в качестве ингибиторов киназ | |
EA201400701A1 (ru) | Замещенные соединения пиразоло[1,5-a]пиридина в качестве ингибиторов тропомиозинрецепторной киназы (trk) | |
PE20151764A1 (es) | Derivados de pirrolo[2,3-d]pirimidina | |
EP4295841A3 (en) | Sulfur (vi) fluoride compounds and their use in click-reaction | |
PH12014501486A1 (en) | Novel nicotinamide derivative or salt thereof | |
PH12014501719A1 (en) | Pyridone derivatives | |
EA201001682A1 (ru) | Производные фенил- и бензодиоксинилзамещенных индазолов | |
EA201201663A1 (ru) | Производные 2-(ариламино)-3н-имидазо[4,5-b]пиридин-6-карбоксамида и их применение в качестве ингибиторов mpges-1 | |
WO2014081697A3 (en) | Anthelmintic compounds and compositions and method of using thereof | |
EA201400833A1 (ru) | Новые индолизиновые соединения, способ их получения и фармацевтические композиции, содержащие их | |
NO20082975L (no) | Nye cykliske ureaderivater, fremstilling derav og farmasoytisk anvendelse derav som kinaseinhibitorer | |
MY194307A (en) | Pyridone derivative having tetrahydropyranylmethyl group | |
AU2012204982A8 (en) | 2,4-diamino-6,7-dihydro-5H-pyrrolo[2,3]pyrimidine derivatives as FAK/Pyk2 inhibitors | |
MX2010004293A (es) | Derivados de 6-aril/heteroalquiloxi benzotiazol y bencimidazol, su procedimiento de preparacion, su aplicacion como medicamentos, composiciones farmaceuticas y nuevo uso principalmente como inhibidores de cmet. | |
CR20130501A (es) | Derivados novedosos de cefalosporinas y composiciones farmacéuticas de estos | |
EA201491376A1 (ru) | Производные 1h-пирроло[2,3-b]пиридина и их применение в качестве ингибиторов киназы | |
BRPI0916385A2 (pt) | derivados de carbamatos de alquiltiazóis, sua respectiva preparação e sua respectiva aplicação em terapêutica | |
EA201001481A1 (ru) | Производные третичного амина в качестве ингибиторов фосфодиэстеразы-4 | |
PL401473A1 (pl) | Nowe, silnie fluorescencyjne substancje heterocykliczne i sposób ich otrzymywania | |
EA200970364A1 (ru) | Новые производные имидазолонов в качестве лекарственных средств, способ их получения, фармацевтические композиции и применение в качестве ингибиторов протеинкиназ, в частности, cdc7 | |
CY1116739T1 (el) | Μεθοδος συνθεσης και κρυσταλλικη μορφη του υδροχλωρικου 4-{3-[cis-εξαϋδροκυκλοπεντα[c]πυρρολ-2(1η)-υλ] προποξυ} βενζαμιδιου καθως και η συνδεομενη ελευθερη βαση και οι φαρμακευτικες συνθεσεις οι οποιες τις περιεχουν | |
EA201590372A1 (ru) | Бициклические гетероарилциклоалкилдиаминовые производные в качестве ингибиторов тирозинкиназ селезенки (syk) |